Siena, Italy

Chiara Caramelli

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Siena Biotech S.p.a.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chiara Caramelli. Retrieved from https://idiyas.com/inventor/chiara-caramelli-d7tlsb96

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chiara Caramelli: Innovator in Hedgehog Pathway Research

Introduction

Chiara Caramelli is a prominent inventor based in Siena, Italy. She has made significant contributions to the field of pharmaceutical research, particularly in the modulation of the hedgehog signaling pathway. Her innovative work has the potential to lead to new therapeutic applications.

Latest Patents

Chiara holds a patent titled "Hedgehog pathway antagonists and therapeutic applications thereof." This patent focuses on heterocyclic compounds that modulate the hedgehog signaling pathway, along with their pharmaceutical compositions and therapeutic applications. She has 1 patent to her name, showcasing her expertise in this specialized area.

Career Highlights

Chiara is currently employed at Siena Biotech S.p.A., where she continues to advance her research in the pharmaceutical industry. Her work is instrumental in developing new treatments that could benefit patients suffering from various conditions related to the hedgehog signaling pathway.

Collaborations

Throughout her career, Chiara has collaborated with notable colleagues, including J Russell Thomas and Galla Pericot Mohr. These partnerships have enriched her research and contributed to the advancement of innovative solutions in her field.

Conclusion

Chiara Caramelli is a dedicated inventor whose work in hedgehog pathway research is paving the way for new therapeutic options. Her contributions to the pharmaceutical industry are noteworthy and reflect her commitment to innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…